ChromaCon AG Zürich, Switzerland

ChromaCon is a supplier of high performance chromatographic process solutions for the (bio)-pharmaceutical industry. We enable our customers to maximize the performance of their chromatographic purification processes for therapeutic proteins and peptides.

With ChromaCon's proprietary MCSGP-technology, our customers can increase the productivity of their conventional chromatographic process by up to 10-fold with even higher yields. In addition, also the buffer and solvent consumption can be drastically reduced.

This boost in performance is achieved due to the highly efficient use of the stationary phase and due to the countercurrent operation principle of the MCSGP-technology. The MCSGP-process is a multi-column chromatographic process which is operated in a continuous manner. It is a platform technology and can be operated with any chromatographic principle, e.g. CEX, AEX, RP, HIC, SEC, multi-modal.

Latest News:

04/2010: Novo Nordisk and ChromaCon jointly present results of insulin purification by MCSGP on RECOVERY-2010 conference. (... more)

03/2010: Pfizer publishes results of mAb-purification process with MCSGP. (... more)

02/2010: Roche and ChromaCon jointly present results of mAb-variant separation with MCSGP on BioProcess International 2010 conference. (... more)